Functional decline in lower-extremity peripheral arterial disease: associations with comorbidity, gender, and race.
about
Spatiotemporal Changes Posttreatment in Peripheral Arterial DiseaseAssociations of calf skeletal muscle characteristics and peripheral nerve function with self-perceived physical functioning and walking ability in persons with peripheral artery disease.Physical activity, ambulation, and comorbidities in people with diabetes and lower-limb amputation.Family history of peripheral artery disease is associated with prevalence and severity of peripheral artery disease: the San Diego population study.Soluble P-selectin predicts lower extremity peripheral artery disease incidence and change in the ankle brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA).The effects of observation of walking in a living room environment, on physical, cognitive, and quality of life related outcomes in older adults with dementia: a study protocol of a randomized controlled trial.Association between physical activity and peripheral artery disease and carotid artery stenosis in a self-referred population of 3 million adultsAssessing walking speed in clinical research: a systematic reviewPersistent depressive symptoms and functional decline among patients with peripheral arterial diseaseRelationship between test methodology and mean velocity in timed walk tests: a review.Women with peripheral arterial disease experience faster functional decline than men with peripheral arterial diseaseLong-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease.Ankle-brachial index predicts change over time in functional status in the San Diego Population Study.Exploring the factors that influence functional performance among nursing home residents.Cilostazol does not improve peripheral arterial disease-linked oxidative stress.Relationship of femoral artery ultrasound measures of atherosclerosis with chronic kidney disease.Toxicity of a novel therapeutic agent targeting mitochondrial complex I.Alterations in gait parameters with peripheral artery disease: The importance of pre-frailty as a confounding variable.Comorbidity, socioeconomic status and multiple sclerosis
P2860
Q26771791-16C58108-BAF9-4F20-BC60-A12EBF39636CQ33667430-9C211569-F8B0-443E-BFBB-DE8FD427ECB3Q33810604-0B5804F9-8EBC-4F0B-8EA2-1F90F2673537Q34216609-7B2C41F5-4AFB-4076-ACEF-61F41DAD3CF1Q35181322-AA025F1D-DAD4-496C-AFA5-06F3A88563D9Q35530139-8A0FF77C-0840-4579-A4CD-D6AEF69F8F6DQ35899907-FA463066-5D77-49B0-B0FA-1AF61AA511D9Q37067680-4F088EAD-EC80-4D36-8F26-7D96EA9DA9FAQ37104650-B465F8BF-D1B6-4B8C-B7D9-3F6385C3B4B7Q37138109-F7E10C8C-9D3E-4CCF-B9C7-076B035C9B23Q37361875-A83DD4AF-5FEC-493C-8B59-5D9C87BB4978Q39267244-234BA651-6B52-403C-A3B7-4395C19A3C0BQ40771541-DAD8F592-16E3-48F1-B84D-4F16E4B9C338Q44796424-45B58B42-759A-4B5D-BB7A-48EF8F59C5ECQ46814741-D2B3BEEC-AFEA-44E4-A715-884A9FAF2E99Q47669314-D346B9A5-B26F-4610-8791-F96A006BC389Q47684621-4C96A34E-4F23-4BED-9D7B-4F4C71FB002AQ51807275-60D50623-80CA-49DB-85C3-60ECD75851B4Q57913787-4F1B7481-C317-4CEA-81FA-31309093717A
P2860
Functional decline in lower-extremity peripheral arterial disease: associations with comorbidity, gender, and race.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Functional decline in lower-ex ...... comorbidity, gender, and race.
@ast
Functional decline in lower-ex ...... comorbidity, gender, and race.
@en
type
label
Functional decline in lower-ex ...... comorbidity, gender, and race.
@ast
Functional decline in lower-ex ...... comorbidity, gender, and race.
@en
prefLabel
Functional decline in lower-ex ...... comorbidity, gender, and race.
@ast
Functional decline in lower-ex ...... comorbidity, gender, and race.
@en
P2093
P1476
Functional decline in lower-ex ...... comorbidity, gender, and race.
@en
P2093
Jack M Guralnik
Mary M McDermott
Philip Greenland
P304
P356
10.1016/J.JVS.2005.08.010
P577
2005-12-01T00:00:00Z